Search company, investor...

Oreka

oreka.com

Total Raised

$24.61M

Investors Count

2

Funding, Valuation & Revenue

3 Fundings

Oreka has raised $24.61M over 3 rounds.

Oreka's latest funding round was a Acquired for on March 31, 2002.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/31/2002

Acquired

Undisclosed Investors

0

FY undefined

1

10/18/2000

Series A

$99M

0

FY undefined

10

5/1/2000

Corporate Minority

$99M

0

FY undefined

10

Date

3/31/2002

10/18/2000

5/1/2000

Round

Acquired

Series A

Corporate Minority

Amount

$99M

$99M

Investors

Undisclosed Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

This profile has not been claimed.

You're more than your latest funding, tell our customers your company's story.

Oreka Investors

2 Investors

Oreka has 2 investors. Initiative IP invested in Oreka's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/18/2000

10/18/2000

1
Series A

Incubator/Accelerator

France

00/00/0000

00/00/0000

iBazar

Subscribe to see more

Corporation

France

First funding

10/18/2000

00/00/0000

Last Funding

10/18/2000

00/00/0000

Investor

iBazar

Rounds

1
Series A

Subscribe to see more

Board Seats

Type

Incubator/Accelerator

Corporation

Location

France

France

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.